| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.061 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.07 | 0.7 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.063 | 0.7 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |